Uroplasty, Inc. recently announced an expansion of coverage of percutaneous nerve stimulation (PTNS) using its Urgent PC neuromodulation system for the treatment of symptoms of overactive bladder syndrome.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.